IFNG and chronic granulomatous disease: IFNγ, is used principally for the treatment of chronic granulomatous disease (CDG), a rare congenital disorder characterized by a lack of superoxide and hydrogen peroxide production by macrophages and susceptibility to bacterial and fungal infections [136].